Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial
Clinical trial NCT06176534 · RECRUITING
Trial details
- NCT number
- NCT06176534
- Sponsor
- Henan Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-01
- Primary completion
- 2025-12-20
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.